Global infrastructure stocks, while posting a gain in the third quarter, were unable to keep pace with the broader market.
Sanofi acquires Dynavax for $2.2B, boosting its vaccine portfolio with HEPLISAV-B and a shingles candidate. Click for my ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback